CVS Health (NYSE:CVS – Get Free Report) had its price target lifted by equities researchers at HSBC from $83.00 to $85.00 in a report released on Tuesday,MarketScreener reports. The brokerage currently has a “hold” rating on the pharmacy operator’s stock. HSBC’s price objective would indicate a potential upside of 3.75% from the stock’s previous close.
Other equities analysts have also issued research reports about the stock. Bank of America dropped their price target on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. Robert W. Baird raised their target price on shares of CVS Health from $92.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, April 15th. Piper Sandler cut their target price on shares of CVS Health from $101.00 to $99.00 and set an “overweight” rating for the company in a research report on Tuesday, March 31st. The Goldman Sachs Group upped their price target on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Finally, Sanford C. Bernstein raised CVS Health from a “market perform” rating to an “outperform” rating and raised their price target for the company from $91.00 to $94.00 in a research report on Thursday, March 12th. Twenty research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.61.
View Our Latest Research Report on CVS
CVS Health Stock Performance
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm’s revenue was up 8.2% compared to the same quarter last year. During the same period last year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities research analysts forecast that CVS Health will post 7.14 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Swiss RE Ltd. bought a new stake in shares of CVS Health in the fourth quarter valued at about $26,000. Sankala Group LLC acquired a new stake in CVS Health during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd increased its stake in CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 281 shares during the period. Mcguire Capital Advisors Inc. acquired a new position in CVS Health in the 4th quarter valued at approximately $28,000. Finally, Ares Financial Consulting LLC bought a new stake in shares of CVS Health in the 4th quarter worth approximately $29,000. Institutional investors own 80.66% of the company’s stock.
CVS Health Company Profile
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Articles
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
